Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GREAT-PD ambroxol pharmacokinetics study in early Parkinson's disease
NL-OMON60750Phase 1Recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, single-arm trial of ambroxol in Parkinson's disease (PD), sponsored by University Medical Center Groningen. Started Mar 2026; status: recruiting.
02
Drugs
ambroxol
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NL-OMON60750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60750.